Palvella Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	63.57	83.6	7.35	38.64	117.76	70.44
Short-Term Investments	-	-	-	20.53	-	-
Cash & Short-Term Investments	63.57	83.6	7.35	59.17	117.76	70.44
Cash Growth	228.29%	1037.44%	-87.58%	-49.76%	67.19%	-32.37%
Accounts Receivable	-	0.36	-	5.81	3.31	1.71
Other Receivables	2.22	1.98	-	5.23	-	-
Total Trade Receivables	2.22	2.34	-	11.04	3.31	1.71
Other Current Assets	1.15	2.3	0.2	3.21	6.55	3.58
Total Current Assets	66.94	88.23	7.55	73.42	127.63	75.72
Net Property, Plant & Equipment	-	-	-	20.7	23.03	25.98
Other Long-Term Assets	-	-	-	1.37	2.9	3.31
Total Assets	66.94	88.23	7.55	95.49	153.56	105.01
Accounts Payable	3.48	4.59	0.94	4.15	8.61	1.79
Accrued Expenses	4.62	5.47	1.42	10.75	16.84	7.73
Current Portion of Leases	-	-	-	0.86	-	-
Unearned Revenue	-	-	-	20.82	25.12	12.63
Other Current Liabilities	2.22	1.98	-	-	-	-
Total Current Liabilities	10.31	12.04	2.36	36.58	50.56	22.15
Long-Term Leases	-	-	-	12.24	13.84	15.93
Other Long-Term Liabilities	17.94	13.59	9.07	18.73	38.4	35.91
Total Long-Term Liabilities	17.94	13.59	9.07	30.98	52.24	51.84
Total Liabilities	28.26	25.63	11.43	67.56	102.81	73.98
Preferred Stock	-	-	70.6	-	-	-
Common Stock	0.01	0.01	-	0.07	0.07	0.06
Additional Paid-in Capital	161.3	156.33	1.82	318.53	307	242.67
Accumulated Other Comprehensive Income	0.1	0	-	-0.25	0.83	-0.3
Retained Earnings	-122.74	-93.74	-76.3	-290.42	-257.14	-211.41
Total Common Shareholders' Equity	38.68	62.61	-3.88	27.93	50.76	31.03
Shareholders' Equity	38.68	62.61	-74.48	27.93	50.76	31.03
Total Liabilities & Equity	66.94	88.23	7.55	95.49	153.56	105.01
Total Debt	-	0	0	13.1	13.84	15.93
Net Cash (Debt)	63.57	83.6	7.35	46.07	103.92	54.5
Net Cash Growth	-23.96%	1037.44%	-84.05%	-55.67%	90.67%	-38.53%
Net Cash Per Share	0.02	37.56	4.10	8.05	128.80	80.03
Book Value	38.68	62.61	-3.88	27.93	50.76	31.03
Book Value Per Share	0.01	28.13	-2.16	4.88	62.91	45.56
Tangible Book Value	38.68	62.61	-3.88	27.93	50.76	31.03
Tangible Book Value Per Share	0.01	28.13	-2.16	4.88	62.91	45.56

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q